Humana (HUM) – Reuters
-
Health insurer Humana warns of hit to 2025 profit, shares sink
-
Humana warns high medical costs may hit 2024 forecast, shares slump
-
Cigna abandons pursuit of Humana, plans $10 billion share buyback -sources
-
US health insurers Humana, Cigna in talks to merge -source
-
Humana flags higher medical costs could hurt 2024 profit growth
-
Humana beats profit estimates on less-than-feared demand for surgeries
-
Humana joins UnitedHealth in flagging cost hit from rising surgeries
-
Humana lifts profit outlook as medical costs drop in govt plans
-
Humana to exit employer insurance business to focus on government plans
-
Humana profit beats estimates as investment income exceeds expectations
-
Humana profit beats as medical costs ease on slow elective-care rebound
-
Cano Health exploring sale after receiving buyout interest
-
Humana's cautious outlook fails to impress investors
-
Humana to sell majority stake in hospice business to CD&R for $2.8 billion
-
Humana to name two independent directors in agreement with Starboard
-
Humana warns of hit to 2021 profit due to COVID-19 uncertainty
-
Humana CFO to step down
-
Walmart to sell Medicare plans in latest healthcare push
-
Oracle wins cloud business from McDonald's, Albertson's
-
CVS raises profit forecast, in talks with government to administer COVID-19 vaccines
-
Wall St. ends near flat; healthcare shares gain but trade deal delay weighs
-
Exclusive: Walgreens has explored taking drug store chain private - sources
-
UnitedHealth sees 2020 profit above Street target; shares climb 8%
-
Wall Street jumps as Powell hints interest rate hikes may taper off
-
CVS, Aetna win U.S. approval for $69 billion deal
-
Cigna deal gets antitrust nod, positive sign for CVS/Aetna
-
U.S. to boost drug price negotiation in Medicare Advantage health plans
-
Humana eyes stronger ties with Walmart despite Walgreens partnership
-
U.S. to consider expanding Medicare drug price negotiation
-
UnitedHealth earnings ease investor worries over flu season, stock up
-
Wall Street tumbles on tech sector, trade war worries
-
CVS pledges to reinvest much of its tax savings, shares fall
-
Humana in talks to buy Kindred Healthcare with equity firms: source
-
CVS likely wants FTC antitrust review, not Justice Department, of Aetna deal
-
CVS, Aetna executives defend $69 billion deal to skeptical Wall Street
-
Exclusive: CVS eyes major expansion of health clinics with Aetna deal - sources
-
Anthem top executive Swedish to become adviser, Boudreaux named CEO
-
CVS deal for Aetna could help retailer face Amazon entry: analysts
-
Exclusive: T-Mobile, Sprint plan merger without selling assets
-
Big-name U.S. hedge funds shed healthcare stocks during the rally in second-quarter
-
Humana out of individual market, with or without Obamacare repeal
-
Aetna fully exits Obamacare exchanges with pull-out in two states
-
Insurer Aetna posts loss, evaluates Obamacare exposure
-
U.S. appeals court blocks Anthem bid to merge with rival Cigna
-
Anthem likely to pull back from Obamacare markets in 2018: Jefferies
-
Insurer Aetna sees Obamacare changes ahead; no word on Humana
-
Health insurer Anthem could rise 30 percent on earnings potential: Barron's
-
Aetna, Humana to consider all options after court blocks merger
-
Trump victory clouds outlook for Time Warner-AT&T, other mergers
-
Exclusive: U.S. states join Dow-DuPont merger probe - sources
Back to HUM Stock Lookup
